Read the latest epilepsy news from Epilepsy Society.
Epilepsy Society welcomes Government decision to relax licensing of medicinal cannabis
27 July 2018
A government decision to relax the licensing laws around cannabis-derived medicinal products has been welcome by Epilepsy Society.
Protein found in worms helps to stop seizure activity
16 July 2018
Exciting new research that involves using a protein in worms to suppress seizures, could spell hope in the future for thousands of people with epilepsy.
Epilepsy Society's CEO writes to Flynn Pharma and Pfizer on NHS's 70th Birthday
5 July 2018
Epilepsy Society's CEO, Clare Pelham, wrote to the pharmaceutical companies Flynn Pharma and Pfizer to ask them to give a birthday present to the NHS.
Epilepsy Society welcomes government response to Billy Caldwell case
16 June 2018
Epilepsy Society welcomes Home Office decision to return the cannabis oil that it confiscated from mother of boy with severe epilepsy.
Tribunal overrules findings in case involving epilepsy drug
8 June 2018
A decision by the Competition and Markets Authority to fine Pfizer and Flynn Pharma a total of £90m for overcharging for an epilepsy drug, has been remitted back to...
Clare Pelham comments on new sodium valproate regulations
30 April 2018
Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.
Charity tells health secretary new drug regulations could fail without public campaign
24 April 2018
Epilepsy Society today welcomes new regulatory measures to stop babies being born with avoidable disabilities after being exposed to the drug, sodium valproate, in...
Poster campaign raises awareness of epilepsy on public transport
23 April 2018
This week, for the first time ever, epilepsy is featuring as part of a high profile poster campaign across London's underground and bus networks.